Biotheus Inc and Hansoh Pharmaceutical Group Co Ltd have announced an extension of their strategic collaboration building upon their existing partnership since In this expanded agreement
Charles River Laboratories International Inc and Navega Therapeutics Inc a biotech company specializing in epigenetic gene therapies have recently unveiled a collaborative agreement for an AAV
Antheia a company focused on revolutionizing essential medicines supply chains through innovative pharmaceutical ingredients has announced a partnership with Olon Group a prominent player
PureTech Health plc a clinicalstage biotherapeutics company has announced that the US Food and Drug Administration has granted orphan drug designation to LYT for the treatment of AML
Prilenia Therapeutics BV a company specializing in the development of innovative therapies for neurodegenerative diseases and neurodevelopmental disorders has announced its intention to submit a Marketing Authorization Application
Pearl Bio a synthetic biology company supported by Khosla Ventures has announced a significant partnership today with Merck known as MSD outside the United States and Canada The collaboration involves a license
Lantern Pharma Inc an artificial intelligence company developing targeted and transformative cancer therapies using its proprietary AI and machine learning platform RADR with multiple clinical stage drug
Nuvation Bio Inc a biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates today announced that the first patient has been dosed
Madrigal Pharmaceuticals Inc a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis today announced that the US Food and Drug Administration
Poseida Therapeutics Inc a clinicalstage cell and gene therapy company advancing a new class of treatments for patients with cancer and rare diseases
Netheravon Rd, Singapore
ExCel, London
San Diego | USA
Boston, MA, USA
San Diego, USA
New Jersey, USA
London, UK
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
Kate, Editorial Team at Pharma Focus Europe, leverages her extensive background in pharmaceutical communication to craft insightful and accessible content. With a passion for translating complex pharmaceutical concepts, Kate contributes to the team's mission of delivering up-to-date and impactful information to the global Pharmaceutical community.
In the everevolving landscape of biological medicines biosimilars have emerged as a costeffective alternative to their reference products For market access in the European Union biosimilars must comply
The pharmaceutical industry is renowned for its stringent regulations complex supply chains and crucial emphasis on data integrity In recent years the emergence of blockchain technology has sparked considerable interest
In a world of increasingly personalized medicine the fields of pharmacogenetics and pharmacogenomics are gaining importance These disciplines explore the relationship between an individuals genetic makeup
In the everevolving world of pharmaceuticals fostering collaboration is essential for driving innovation and meeting the diverse needs of patients However this seemingly simple goal is often hindered by numerous challenges
With the rise of drug counterfeiting posing a serious threat to global public health the role of technology in anticounterfeiting efforts has become increasingly vital As counterfeit drugs continue to infiltrate the market
Pharmacology the study of drugs and their effects on living organisms is a multifaceted field crucial to the development and improvement of pharmaceuticals Bioassay a method that assesses the potency of substances
AbstractSimple rapid and sensitive spectroscopic methods were developed and validated for the determination of antiviral agents namely penciclovir PCV and entecavir ETV The first method is based on measuring the native fluorescence of each of the cited drugs at its optimum excitation and emission wavelengths The fluorescence intensity was measured for PCV
Zanidatamab a bispecific antibody developed for the treatment of patients with previouslytreated HER geneamplified Biliary Tract Cancer BTC Zanidatamab is built on Zymeworks Azymetric platform binding two nonoverlapping epitopes of HER known asbiparatopic binding
Biotechnology an industry at the forefront of scientific innovation and transformative healthcare solutions
Recent industry pressures brought on by the global COVID pandemic provided critical lessons for the life sciences industry
Today there are more than known rare diseases defined by the European Union as conditions that affect less than in people
Continuous manufacturing methods have been extensively demonstrated to have a significant impact on improving quality
In drug discovery AI is being used to predict the efficacy and safety of potential drug candidates identify new therapeutic targets and optimize clinical trial designs
With more clinical trials getting decentralized and the adoption of AIML witnessing an upward trend